Sponsored by
Researchers at the University of Cincinnati and Johns Hopkins reported promising preclinical results for a novel 'NanoMesh' implant designed to deliver multiple anti-cancer drugs directly into the surgical cavity after glioblastoma (GBM) resection. In mouse models, the multi-layered nanofiber device released temozolomide, acriflavine, and PT2385 in a controlled fashion, significantly extending survival. While this technology is still in the preclinical stage, it's an interesting new approach to local drug delivery for GBM.